Biote Corp (BTMD)

Feb 26, 2025, 4:05 PM EST - 10 days ago

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

Jan 30, 2025, 4:10 PM EST - 5 weeks ago

Biote Announces CEO Retirement and Succession Plan

Nov 13, 2024, 2:56 AM EST - 4 months ago

biote Corp. (BTMD) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:05 PM EST - 4 months ago

Biote Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 4:05 PM EDT - 4 months ago

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

Aug 10, 2024, 2:42 PM EDT - 7 months ago

biote Corp. (BTMD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 7 months ago

Biote Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:05 PM EDT - 8 months ago

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Jun 20, 2024, 4:45 PM EDT - 9 months ago

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

May 9, 2024, 3:58 AM EDT - 10 months ago

biote Corp. (BTMD) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 10 months ago

Biote Reports First Quarter 2024 Financial Results

Apr 29, 2024, 4:05 PM EDT - 11 months ago

Biote Announces Definitive Settlement with Founder

Apr 23, 2024, 4:05 PM EDT - 11 months ago

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

Mar 15, 2024, 2:33 PM EDT - 1 year ago

This overlooked corner of women's health could be a $350 billion market opportunity

PFE PGNY VTGN DARE

Mar 12, 2024, 7:45 PM EDT - 1 year ago

biote Corp. (BTMD) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 4:05 PM EDT - 1 year ago

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27, 2024, 4:05 PM EST - 1 year ago

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

Feb 20, 2024, 4:05 PM EST - 1 year ago

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares

Jan 25, 2024, 4:05 PM EST - 1 year ago

Biote Announces $20 Million Share Repurchase Authorization

Jan 17, 2024, 4:05 PM EST - 1 year ago

Biote to Purchase Asteria Health

Jan 17, 2024, 4:05 PM EST - 1 year ago

Biote Provides Preliminary 2023 Results and Initial 2024 Guidance

Jan 11, 2024, 4:05 PM EST - 1 year ago

Biote Names Robert Peterson as Chief Financial Officer

Nov 29, 2023, 11:34 PM EST - 1 year ago

biote Should Keep Delivering Strong Growth

Nov 7, 2023, 4:45 PM EST - 1 year ago

Biote Reports Third Quarter 2023 Financial Results

Oct 24, 2023, 8:30 AM EDT - 1 year ago

Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call

Aug 10, 2023, 4:30 PM EDT - 1 year ago

Biote Reports Second Quarter 2023 Financial Results

Jul 27, 2023, 8:30 AM EDT - 1 year ago

Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call

Jun 22, 2023, 7:00 AM EDT - 1 year ago

Biote Formalizes Commitment to Men's Hormone Health With Launch of New Men's Health Division

Jun 8, 2023, 6:05 PM EDT - 1 year ago

Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants

Jun 5, 2023, 7:48 AM EDT - 1 year ago

Biote Announces Pricing of Secondary Offering of Common Stock

May 31, 2023, 8:30 AM EDT - 1 year ago

Biote to Participate at Upcoming Investor Conferences

May 30, 2023, 8:30 AM EDT - 1 year ago

Biote Appoints Mary J. Puncochar as Chief Commercial Officer

May 9, 2023, 5:21 PM EDT - 1 year ago

Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

May 9, 2023, 5:21 PM EDT - 1 year ago

Biote Reports First Quarter 2023 Financial Results

Apr 26, 2023, 8:30 AM EDT - 2 years ago

Biote Schedules First Quarter 2023 Financial Results Release and Conference Call

Apr 10, 2023, 8:30 AM EDT - 2 years ago

Biote Names John Denne as General Manager, Men's Health Division

Mar 28, 2023, 4:15 PM EDT - 2 years ago

Biote Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 27, 2023, 9:00 AM EDT - 2 years ago

Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report

Mar 2, 2023, 8:00 AM EST - 2 years ago

Biote to Present at 35th Annual Roth Conference

Feb 9, 2023, 4:15 PM EST - 2 years ago

Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call

Jan 9, 2023, 5:30 PM EST - 2 years ago

Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters' Over-Allotment Option

Nov 10, 2022, 8:30 AM EST - 2 years ago

Biote to Present at Jefferies London Healthcare Conference

Nov 8, 2022, 4:15 PM EST - 2 years ago

Biote Reports Third Quarter Financial Results

Nov 7, 2022, 9:15 AM EST - 2 years ago

Biote Appoints Debby Morris to Board of Directors

Oct 31, 2022, 8:30 AM EDT - 2 years ago

Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call

Oct 10, 2022, 7:45 AM EDT - 2 years ago

Biote Releases Updated Corporate Presentation for October 2022

Sep 7, 2022, 8:30 AM EDT - 2 years ago

Biote Announces Strategic Partnership with IMAC Holdings, Inc.

BACK

Aug 25, 2022, 4:05 PM EDT - 2 years ago

Biote Announces Approval to Relist on The Nasdaq Stock Market

Aug 24, 2022, 8:30 AM EDT - 2 years ago

Biote Appoints Samar Kamdar as Chief Financial Officer

Aug 15, 2022, 4:56 PM EDT - 2 years ago

Biote Issues Correction to Second Quarter Operating Loss and Net Income